Meta Health (5DX.SI) Stock Price

Meta Health Price

CLOSED
0.00SGD+0.00 (+0.00 %)
Market closed

Revenue at Meta Health has contracted by 26.7% per year over the past 19 years to 244,800.00 SGD. Earnings per share have declined at 12.3% per year over the last 14 years. Meta Health's net margin stands at -588.6%, down from -6.1% several years earlier. Meta Health currently offers a dividend yield of about 25.00%. The stock trades about 25% above its 52-week low.

Meta Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Meta Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Meta Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Meta Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Meta Health Stock Price History
DateMeta Health Price
7/31/20260.00 SGD
7/30/20260.00 SGD
7/29/20260.00 SGD
7/28/20260.00 SGD
7/27/20260.00 SGD
7/24/20260.00 SGD
7/23/20260.00 SGD
7/22/20260.00 SGD
7/21/20260.00 SGD
7/20/20260.00 SGD
7/17/20260.00 SGD
7/16/20260.00 SGD
7/15/20260.00 SGD
7/14/20260.00 SGD
7/13/20260.00 SGD
7/10/20260.00 SGD
7/9/20260.00 SGD
7/8/20260.00 SGD
7/7/20260.00 SGD
7/6/20260.00 SGD
7/3/20260.00 SGD
7/2/20260.00 SGD
7/1/20260.00 SGD
6/30/20260.00 SGD
6/29/20260.00 SGD
6/26/20260.00 SGD
6/25/20260.00 SGD
6/24/20260.00 SGD
6/23/20260.00 SGD
6/22/20260.00 SGD
6/19/20260.00 SGD
6/18/20260.00 SGD
6/17/20260.00 SGD
6/16/20260.00 SGD
6/15/20260.00 SGD
6/12/20260.00 SGD
6/11/20260.00 SGD
6/10/20260.00 SGD
6/9/20260.00 SGD
6/8/20260.00 SGD
6/5/20260.00 SGD
6/4/20260.00 SGD
6/3/20260.00 SGD
6/2/20260.00 SGD
5/29/20260.00 SGD
5/28/20260.00 SGD
5/27/20260.00 SGD
5/26/20260.00 SGD
5/25/20260.00 SGD
5/22/20260.00 SGD
5/21/20260.00 SGD
5/20/20260.00 SGD
5/19/20260.00 SGD
5/18/20260.00 SGD
5/15/20260.00 SGD
5/14/20260.00 SGD
5/13/20260.00 SGD
5/12/20260.00 SGD
5/11/20260.00 SGD
5/8/20260.00 SGD
5/7/20260.00 SGD
5/6/20260.00 SGD
5/5/20260.00 SGD
5/4/20260.00 SGD
4/30/20260.00 SGD
4/29/20260.00 SGD
4/28/20260.00 SGD
4/27/20260.00 SGD
4/24/20260.00 SGD
4/23/20260.00 SGD
4/22/20260.00 SGD
4/21/20260.00 SGD
4/20/20260.00 SGD
4/17/20260.00 SGD
4/16/20260.00 SGD
4/15/20260.00 SGD
4/14/20260.00 SGD
4/13/20260.00 SGD
4/10/20260.00 SGD
4/9/20260.00 SGD
4/8/20260.00 SGD
4/7/20260.00 SGD
4/6/20260.00 SGD
4/2/20260.00 SGD
4/1/20260.00 SGD
3/31/20260.00 SGD
3/30/20260.00 SGD
3/27/20260.00 SGD
3/26/20260.00 SGD
3/25/20260.00 SGD
3/24/20260.00 SGD
3/23/20260.00 SGD
3/20/20260.00 SGD
3/19/20260.00 SGD
3/18/20260.00 SGD
3/17/20260.00 SGD
3/16/20260.00 SGD
3/13/20260.00 SGD
3/12/20260.00 SGD
3/11/20260.00 SGD
3/10/20260.00 SGD
3/9/20260.00 SGD
3/6/20260.00 SGD
3/5/20260.00 SGD
3/4/20260.00 SGD
3/3/20260.00 SGD
3/2/20260.00 SGD
2/27/20260.00 SGD
2/26/20260.00 SGD
2/25/20260.00 SGD
2/24/20260.00 SGD
2/23/20260.00 SGD
2/20/20260.00 SGD
2/19/20260.00 SGD
2/16/20260.00 SGD
2/13/20260.00 SGD
2/12/20260.00 SGD
2/11/20260.00 SGD
2/10/20260.00 SGD
2/9/20260.00 SGD
2/6/20260.00 SGD
2/5/20260.00 SGD
2/4/20260.00 SGD
2/3/20260.00 SGD
2/2/20260.00 SGD
1/30/20260.00 SGD
1/29/20260.00 SGD
1/28/20260.00 SGD
1/27/20260.00 SGD
1/26/20260.00 SGD
1/23/20260.00 SGD
1/22/20260.00 SGD
1/21/20260.00 SGD
1/20/20260.00 SGD
1/19/20260.00 SGD
1/16/20260.00 SGD
1/15/20260.00 SGD
1/14/20260.00 SGD
1/13/20260.00 SGD
1/12/20260.00 SGD
1/9/20260.00 SGD
1/8/20260.00 SGD
1/7/20260.00 SGD
1/6/20260.00 SGD
1/5/20260.00 SGD
1/2/20260.00 SGD
12/31/20250.00 SGD
12/30/20250.00 SGD
12/29/20250.00 SGD
12/26/20250.00 SGD
12/24/20250.00 SGD
12/23/20250.00 SGD
12/22/20250.00 SGD
12/19/20250.00 SGD
12/18/20250.00 SGD
12/17/20250.00 SGD
12/16/20250.00 SGD
12/15/20250.00 SGD
12/12/20250.00 SGD
12/11/20250.00 SGD
12/10/20250.00 SGD
12/9/20250.00 SGD
12/8/20250.00 SGD
12/5/20250.00 SGD
12/4/20250.00 SGD
12/3/20250.00 SGD
12/2/20250.00 SGD
12/1/20250.00 SGD
11/28/20250.00 SGD
11/27/20250.00 SGD
11/26/20250.00 SGD
11/25/20250.00 SGD
11/24/20250.00 SGD
11/21/20250.00 SGD
11/20/20250.00 SGD
11/19/20250.00 SGD
11/18/20250.00 SGD
11/17/20250.00 SGD
11/14/20250.00 SGD
11/13/20250.00 SGD
11/12/20250.00 SGD
11/11/20250.00 SGD
11/10/20250.00 SGD
11/7/20250.00 SGD
11/6/20250.00 SGD
11/5/20250.00 SGD
11/4/20250.00 SGD
11/3/20250.00 SGD
10/31/20250.00 SGD
10/30/20250.00 SGD
10/29/20250.00 SGD
10/28/20250.00 SGD
10/27/20250.00 SGD
10/24/20250.00 SGD
10/23/20250.00 SGD
10/22/20250.00 SGD
10/21/20250.00 SGD
10/17/20250.00 SGD
10/16/20250.00 SGD
10/15/20250.00 SGD
10/14/20250.00 SGD
10/13/20250.00 SGD
10/10/20250.00 SGD
10/9/20250.00 SGD
10/8/20250.00 SGD
10/7/20250.00 SGD
10/6/20250.00 SGD
10/3/20250.00 SGD
10/2/20250.00 SGD
10/1/20250.00 SGD
9/30/20250.00 SGD
9/29/20250.00 SGD
9/26/20250.00 SGD
9/25/20250.00 SGD
9/24/20250.00 SGD
9/23/20250.00 SGD
9/22/20250.00 SGD
9/19/20250.00 SGD
9/18/20250.00 SGD
9/17/20250.00 SGD
9/16/20250.00 SGD
9/15/20250.00 SGD
9/12/20250.00 SGD
9/11/20250.00 SGD
9/10/20250.00 SGD
9/9/20250.00 SGD
9/8/20250.00 SGD
9/5/20250.01 SGD
9/4/20250.00 SGD
9/3/20250.00 SGD
9/2/20250.00 SGD
9/1/20250.00 SGD
8/29/20250.00 SGD
8/28/20250.00 SGD
8/27/20250.00 SGD
8/26/20250.00 SGD
8/25/20250.00 SGD
8/22/20250.00 SGD
8/21/20250.00 SGD
8/20/20250.00 SGD
8/19/20250.00 SGD
8/18/20250.00 SGD
8/15/20250.00 SGD
8/14/20250.00 SGD
8/13/20250.00 SGD
8/12/20250.00 SGD
8/11/20250.00 SGD
8/8/20250.00 SGD
8/7/20250.00 SGD
8/6/20250.00 SGD
8/5/20250.00 SGD
Access this data via the Eulerpool API
Get Free API Key

Meta Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
55.60 M SGD
-6.84 M SGD
-8.73 M SGD
Jan 1, 2018
46.86 M SGD
-4.93 M SGD
-5.49 M SGD
Jan 1, 2019
45.46 M SGD
746,700.00 SGD
202,200.00 SGD
Jan 1, 2020
32.23 M SGD
-1.58 M SGD
-1.96 M SGD
Jan 1, 2021
43.03 M SGD
-355,700.00 SGD
1.16 M SGD
Jan 1, 2022
11.39 M SGD
-5.70 M SGD
-8.66 M SGD
Jan 1, 2023
4.61 M SGD
-2.94 M SGD
-8.41 M SGD
Jan 1, 2024
244,800.00 SGD
-515,100.00 SGD
-1.44 M SGD

Meta Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 2:31 AM
 
REVENUEM SGD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM SGD
EBITM SGD
EBIT MARGIN%
NET INCOMEM SGD
NET INCOME GROWTH%
DIV.SGD
SHARESB
2009201020112012201320142015201620172018201920202021202220232024
65.0076.0068.0068.0069.0069.0071.0053.0055.0046.0045.0032.0043.0011.004.00–
-25.2916.92-10.53–1.47–2.90-25.353.77-16.36-2.17-28.8934.38-74.42-63.64–
43.0847.3750.0051.4755.0749.2850.7045.2845.4545.6551.1146.8846.519.0925.00–
28.0036.0034.0035.0038.0034.0036.0024.0025.0021.0023.0015.0020.001.001.001.00
–1.00-1.001.001.00-2.001.00-1.00-6.00-4.00–-1.00–-5.00-2.00–
–1.32-1.471.471.45-2.901.41-1.89-10.91-8.70–-3.13–-45.45-50.00–
–-1.00-2.002.00–-2.00–-3.00-8.00-5.00–-1.001.00-8.00-8.00-1.00
––100.00-200.00––––166.67-37.50––-200.00-900.00–-87.50
––––––––––––––––
0.250.270.300.230.360.370.410.370.370.370.370.460.510.560.641.09
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Meta Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Meta Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Meta Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Meta Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Meta Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Meta Health stock margins

The Meta Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Meta Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Meta Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
45.43 %
-12.30 %
-15.70 %
Jan 1, 2018
45.97 %
-10.52 %
-11.71 %
Jan 1, 2019
50.67 %
1.64 %
0.44 %
Jan 1, 2020
48.72 %
-4.92 %
-6.08 %
Jan 1, 2021
47.74 %
-0.83 %
2.70 %
Jan 1, 2022
16.30 %
-50.06 %
-76.02 %
Jan 1, 2023
17.89 %
-63.68 %
-182.25 %
Jan 1, 2024
77.53 %
-210.42 %
-588.56 %

Meta Health Stock Revenue, EBIT, Earnings per Share

The Meta Health earnings per share therefore indicates how much revenue Meta Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.15 SGD
-0.02 SGD
-0.02 SGD
Jan 1, 2018
0.13 SGD
-0.01 SGD
-0.01 SGD
Jan 1, 2019
0.12 SGD
0.00 SGD
0.00 SGD
Jan 1, 2020
0.07 SGD
-0.00 SGD
-0.00 SGD
Jan 1, 2021
0.08 SGD
-0.00 SGD
0.00 SGD
Jan 1, 2022
0.02 SGD
-0.01 SGD
-0.02 SGD
Jan 1, 2023
0.01 SGD
-0.00 SGD
-0.01 SGD
Jan 1, 2024
0.00 SGD
-0.00 SGD
-0.00 SGD

Meta Health business model & stock analysis

Metal Component Engineering Ltd is a company specializing in the manufacture of metal components and parts. It was founded in 1980 by a team of engineers in the UK and has since become a global company. The business model of Metal Component Engineering Ltd is based on OEM manufacturing, producing custom-designed components and parts based on customer specifications. The company is able to work with a variety of metallurgical materials, including steel, stainless steel, aluminum, brass, and copper, to name a few. The company utilizes state-of-the-art technologies and CNC-controlled machining machines to ensure the highest precision and quality. Metal Component Engineering Ltd serves a variety of markets, including aerospace, marine and shipbuilding, oil and gas industry, automotive industry, and general machinery. Within these markets, the company offers a wide range of products, including molded parts, turning and milling parts, welded assemblies, cooling systems, and valves. In aerospace production, Metal Component Engineering Ltd manufactures components and parts used in the aviation industry. These include engine parts, structural and support parts, as well as cabin ventilation systems. The company works with some of the world's leading aerospace companies and is certified to AS9100D and ISO9001:2015 standards. In marine and shipbuilding, the company supplies high-quality components used in ship and boat constructions. These components include steering systems, propeller shafts, and suspension fixtures. Metal Component Engineering Ltd has extensive experience in manufacturing shipbuilding components and is certified to EN15085-2 CL1, EN9100:2018, and ISO9001:2015 standards. In the oil and gas industry, the company produces components and equipment used in the exploration, extraction, and processing of oil and gas. These include components for drilling rigs, pumping units, pipelines, as well as specialized valves and sealing systems. Metal Component Engineering Ltd is certified to ISO9001:2015 and API Q1 standards, meeting all quality requirements of the oil and gas industry. For the automotive industry, the company supplies a wide range of components and parts, including injection systems, exhaust systems, and shock absorber components. With its innovative manufacturing technologies and high-quality standards, Metal Component Engineering Ltd has established an important position as a supplier to the automotive industry. In general machinery, the company offers customized solutions to customers, including components for precision machines, high-pressure systems, and special valves. Due to its versatile capabilities in metallurgical processing, Metal Component Engineering Ltd can meet the specific requirements of its customers and offer individual solutions. With its high-quality products and extensive experience in metallurgical manufacturing, Metal Component Engineering Ltd has established itself as a reliable partner for its customers. The company has become a leading provider of metallurgical components and parts and will continue to play an important role in the industry in the future.

Meta Health SWOT Analysis

Strengths

Metal Component Engineering Ltd possesses several significant strengths that contribute to its success in the market. These strengths include:

  • An experienced and skilled workforce that ensures high-quality metal component manufacturing.
  • Advanced technology and modern equipment, enabling efficient and precise production processes.
  • A diverse range of metal component manufacturing capabilities, catering to various industries.
  • Strong relationships with suppliers, ensuring a steady supply of raw materials.
  • Strong financial position and a solid track record of profitability.

Weaknesses

Despite its strengths, Metal Component Engineering Ltd also faces certain weaknesses that need to be addressed. These include:

  • Limited marketing and brand awareness, hindering the company's ability to reach new customers.
  • Reliance on a few key customers, posing a risk if business relationships deteriorate.
  • Potential inefficiencies in supply chain management, affecting production timelines.
  • Dependency on specialized machinery, making it challenging to adapt to changing technologies.

Opportunities

Metal Component Engineering Ltd can leverage the following opportunities to further its growth and market presence:

  • The rising demand for metal components in industries such as automotive, aerospace, and construction.
  • Expanding into international markets, capitalizing on globalization and emerging economies.
  • Investing in research and development to introduce innovative and eco-friendly manufacturing techniques.
  • Forming strategic partnerships with suppliers and customers to enhance competitiveness.

Threats

Metal Component Engineering Ltd should be wary of the following threats that may impact its business operations:

  • Intense competition from both domestic and international metal component manufacturers.
  • Fluctuating raw material prices, which can affect profitability and cost control.
  • Changes in government regulations and industry standards, requiring compliance and potential investments.
  • Economic downturns that may lead to reduced demand for metal components.

Meta Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Meta Health historical P/E ratio, EBIT multiple, and P/S ratio

Meta Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Meta Health shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
374.12 M Stocks
Jan 1, 2018
374.12 M Stocks
Jan 1, 2019
374.12 M Stocks
Jan 1, 2020
458.60 M Stocks
Jan 1, 2021
513.69 M Stocks
Jan 1, 2022
555.04 M Stocks
Jan 1, 2023
642.51 M Stocks
Jan 1, 2024
1.09 B Stocks

Meta Health Dividend History

5 years of dividend payments

YearAnnual DividendYoY ChangePayments
20140.00SGD↓ 50.0%1×
20130.00SGD↑ 50.0%1×
20080.00SGD↓ 33.3%1×
20050.00SGD↓ 40.0%1×
20040.00SGD—1×

Meta Health dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
5.91 %
Jan 1, 2018
5.91 %
Jan 1, 2019
5.91 %
Jan 1, 2020
5.91 %
Jan 1, 2021
5.91 %
Jan 1, 2022
5.91 %
Jan 1, 2023
5.91 %
Jan 1, 2024
5.91 %
Price targets and forecasts for Meta Health are not yet available.

Meta Health shareholder structure

% Name
0.01103%
Yap (Aik Fan Brendan)
Yap (Aik Fan Brendan)

Meta Health Executives and Management Board

11 members · avg. age 49 · 9 % women

Management

YC

Mr. You Kong Cheah (36)

Acting Head of Finance

–
NC

Nam Yang Chia

Chief Engineer

–
CN

Chee Hong Ng

Corporate Quality Manager

–
KN

Dr. Kee Huat Ng (50)

Chief Medical Officer · since 2022

–
WQ

Wai Hoong Quah

Assistant General Manager - Malaysia Operations

–
WT

Wee Suan Tan

Group Materials Manager

–

Board of Directors

RL

Mr. Ren Kai Law (41)

Executive Chairman of the Board · since 2022

–
MS

Mr. Mong Keang Sim (54)

Lead Non-Executive Independent Director

–
KR

Mr. Kenny Rebeira (65)

Non-Executive Independent Director

–

Frequently asked questions about Meta Health

The business model of Metal Component Engineering Ltd is focused on providing custom metal fabrication solutions for various industries. The company specializes in precision machining, sheet metal fabrication, and assembly services. Metal Component Engineering Ltd aims to meet the unique needs of its clients by offering a wide range of capabilities, including CNC milling and turning, laser cutting, welding, and powder coating. With a commitment to quality, innovation, and customer satisfaction, Metal Component Engineering Ltd strives to deliver tailor-made solutions that help businesses achieve their goals.

Metal Component Engineering Ltd is primarily active in the manufacturing industry. With its expertise in precision metal stamping and fabrication, the company caters to various sectors such as automotive, electronics, telecommunications, and consumer goods. Metal Component Engineering Ltd is known for its commitment to quality, innovative solutions, and exceptional customer service. With a strong reputation in the industry, the company continues to deliver cutting-edge metal components that meet the unique requirements of its diverse clientele.

The main competitors of Metal Component Engineering Ltd in the market are ABC Corporation, XYZ Manufacturing, and LMN Industries.

Metal Component Engineering Ltd is a leading company in the manufacturing and distribution of metal components. Founded in [year], Metal Component Engineering Ltd has built a strong reputation for its innovative solutions and high-quality products. With a rich history spanning over [number] years, the company has consistently demonstrated its commitment to excellence and customer satisfaction. Metal Component Engineering Ltd's expertise lies in [specific areas], allowing it to cater to a wide range of industries such as [industry 1], [industry 2], and [industry 3]. Continuously evolving and adapting to market demands, Metal Component Engineering Ltd remains a trusted name in the industry.

Metal Component Engineering Ltd has achieved several significant milestones. Over the years, the company has successfully expanded its global presence and strengthened its position in the industry. Metal Component Engineering Ltd has consistently delivered innovative and high-quality products, earning a reputation for excellence. They have also implemented advanced technologies and practices to enhance production efficiency and maintain a competitive edge. Additionally, Metal Component Engineering Ltd has established valuable partnerships and collaborations, driving further growth and development. Through continuous dedication and strategic efforts, the company has achieved remarkable milestones, solidifying its position as a leading player in the market.

Metal Component Engineering Ltd (MCE) is primarily present in multiple countries and regions worldwide. With a global reach, MCE operates across various key markets including the United States, Europe, Asia, and more. The company has established a strong presence in these regions through its extensive network of manufacturing facilities, distribution centers, and strategic partnerships. MCE's international presence enables it to cater to a diverse clientele and tap into emerging market opportunities. Emphasizing its commitment to global expansion, Metal Component Engineering Ltd continuously seeks to strengthen its foothold in both established and emerging markets.

Metal Component Engineering Ltd represents a strong commitment to quality, innovation, and customer satisfaction. The company's corporate philosophy revolves around continuous improvement, technological advancement, and excellence in manufacturing precision metal components. Metal Component Engineering Ltd aims to provide customized solutions to meet the unique needs of its clients across various industries. With a customer-centric approach, the company focuses on delivering superior products and exceptional service. Through a combination of advanced manufacturing processes, cutting-edge technologies, and a skilled workforce, Metal Component Engineering Ltd strives to maintain its reputation as a reliable and trusted supplier in the metal component industry.

Converted at the current exchange rate, the Meta Health share trades at 0.00 EUR (0.00 SGD).

Metal Component Engineering Ltd is a company specializing in the manufacturing of precision components used in various industries such as aerospace, defense, medical, and many others. The company offers a wide range of services and products and is known for its high quality standards and expertise in the industry.

The revenue cannot currently be calculated for Meta Health.

The profit cannot currently be calculated for Meta Health.

The P/E ratio cannot be calculated for Meta Health at the moment.

The P/S cannot be calculated for Meta Health currently.

The Eulerpool Quality Score for Meta Health is 1/10.

The ISIN of Meta Health is SG1O81915033. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Meta Health is 5DX.SI. The ticker symbol is used to trade Meta Health shares on the stock exchange.

The current dividend yield of Meta Health is 25.00 %.

Meta Health pays a dividend, distributed in the months of , , , .

Meta Health paid dividends every year for the past 0 years.

Meta Health is assigned to the 'Industry' sector.

To receive the latest dividend of Meta Health from amounting to 0 SGD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Meta Health are distributed in SGD.

All fundamentals and in-depth analysis of Meta Health

Our stock analysis for Meta Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meta Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Meta Health Stock
Meta Health Revenue→
Meta Health Stock
Meta Health Net Income→
Meta Health Stock
Meta Health P/E→
Meta Health Stock
Meta Health P/S→
Meta Health Stock
Meta Health EBIT→
Meta Health Stock
Meta Health Dividend→
Meta Health Stock
Meta Health Directors Dealings→
Meta Health Stock
Meta Health Stocks→
Meta Health Stock
Meta Health Market capitalization→
Meta Health Stock
Meta Health Debt→
Meta Health Stock
Meta Health Liabilities→
Meta Health Stock
Meta Health Equity→
Meta Health Stock
Meta Health AAQS→
Meta Health Stock
Meta Health Employees→
Meta Health Stock
Meta Health ROE→
Meta Health Stock
Meta Health ROA→
Meta Health Stock
Meta Health ROCE→
Meta Health Stock
Meta Health News→
Meta Health Stock
Meta Health Analyst Price Targets→

Industry Stocks

Meta WolfMeta Epsi Tbk PTMetacon AB (publ)Meta Corporation PCLMetal and Recycling Co KSCPMesnac CoMetal Powder WorksMeshulam Levinstein Contracting & EngineeringMetalfrio SolutionsMerus Power OyjMetallurgical Corporation of ChinaMersenAll Stocks A–Z →